Fig. 1: Subtype-defining alterations and other important genome alterations detected by TAS-LRS and/or clinical tests.
From: Genome profiling with targeted adaptive sampling long-read sequencing for pediatric leukemia
AML, acute myeloid leukemia; B-ALL, B-cell acute lymphoblastic leukemia; T-ALL, T-cell acute lymphoblastic leukemia; TAS-LRS, targeted adaptive sampling long-read sequencing.
